0074-0034 : Zinbryta 150 mg/ml Subcutaneous Injection, Solution
| NDC: | 0074-0034 |
| Labeler: | Abbvie |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Zinbryta Pen |
| Dosage Form: | Subcutaneous Injection, Solution |
| Application #: | BLA761029 |
| Rev. Date: |
NDC Package Codes:
- 0074-0034-01: 1 SYRINGE, GLASS IN 1 BOX (0074‑0034‑01) > 1 ML IN 1 SYRINGE, GLASS
Active Ingredients:
- Daclizumab
Dosage Strength:
- 150 mg/mL
Pharmaceutical Classes:
- Interleukin 2 Receptor Antagonists [MoA]
- Interleukin 2 Receptor-directed Antibody Interactions [MoA]
- Interleukin-2 Receptor Blocking Antibody [EPC]
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0074-0033Next: 0074-0038 >
Related Discussions:
Zinbryta (daclizumab)
My husband spent seven weeks in the hospital, seriously ill. A major contributing factor is believed to be the Zinbryta ... 2 replies
My husband spent seven weeks in the hospital, seriously ill. A major contributing factor is believed to be the Zinbryta ... 2 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.